ClinicalTrials.gg
RecruitingNCT07568990Updated Jun 10, 2026

Ureteral Access Sheaths in Endoscopic Kidney Stone Surgery

An interventional study of Non-aspirating ureteral access sheath and Aspirating ureteral access sheath in Kidney Stones, sponsored by Hitit University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-06-10.

Sponsored by Hitit University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 48 studies in Kidney Calculi with a site in Turkey — 21 open to participants now, 22 under way, none of them phase 3. Kidney Calculi · Turkey.

Planned enrollment
25th of 35
70 · median 90
Started
2026
with 13 others
No phase
32 of 48
15 open now
Primary completion
2027-04
later than 19 of 21 live
Registered
35th of 48
by date
Lead sponsor
5 of 48
Hitit University

Among the 48 studies in Kidney Calculi with a site in Turkey, this one is the 25th largest by planned enrollment of the 35 interventional ones that give a count, is one of 14 that started in 2026, is one of 32 with no phase, reaches primary completion later than 19 of the 21 other live ones, and was the 35th registered.

Kidney Calculi

510 studies on the registry are indexed under Kidney Calculi; 147 are open to participants now.

Browse Kidney Calculi studies →

Open to participants now

21 of the 48 studies in Kidney Calculi with a site in Turkey are open now. Recruiting first, the newest first:

15 more — sign in →

All 21 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 88 Kidney Calculi studies recruiting now, 48 (55%) set no upper age limit and 23 (26%) stop at 75 or younger; 6 take children under 18; 11 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 48 studies in Kidney Calculi with a site in Turkey, or all of them as a file.
02

Study summary

This prospective, randomized, comparative study aims to evaluate the impact of aspirating and non-aspirating ureteral access sheaths on success rates and complications in patients undergoing retrograde intrarenal surgery (RIRS) for kidney stones. A total of 70 patients with renal stones smaller than 2 cm will be enrolled and randomly assigned to two groups. One group will undergo RIRS using a non-aspirating ureteral access sheath, while the other group will be treated using an aspirating ureteral access sheath.

The primary outcome of the study is the stone-free rate, which will be assessed at postoperative follow-up. Secondary outcomes include operative time, fluoroscopy time, length of hospital stay, postoperative complications according to the Clavien-Dindo classification, infection-related parameters, and the need for ureteral stenting.

The study aims to determine whether the use of an aspirating access sheath improves surgical outcomes by reducing intrarenal pressure, enhancing visualization, and decreasing complication rates. The findings are expected to contribute to optimizing device selection and improving clinical outcomes in endoscopic kidney stone surgery.

Read the detailed description

This study is designed as a prospective, randomized, comparative clinical trial to evaluate the effectiveness and safety of aspirating versus non-aspirating ureteral access sheaths in patients undergoing retrograde intrarenal surgery (RIRS) for kidney stones.

Ureteral access sheaths are commonly used during RIRS to facilitate repeated access to the collecting system, maintain low intrarenal pressure, and improve visualization. While conventional non-aspirating sheaths allow passive outflow of irrigation fluid, aspirating sheaths provide active suction, which may enhance fragment evacuation, reduce intrarenal pressure, and potentially decrease infectious complications. However, comparative clinical data between these two approaches remain limited.

In this study, a total of 70 patients aged 18 to 75 years with renal stones smaller than 2 cm will be enrolled after providing informed consent. Patients will be randomized into two groups using a computer-generated block randomization method. The first group will undergo RIRS using a non-aspirating ureteral access sheath, while the second group will undergo RIRS using an aspirating ureteral access sheath. All procedures will be performed using a standardized surgical technique.

Demographic characteristics, stone-related parameters, and perioperative variables will be recorded. Postoperative follow-up will include clinical and radiological evaluation. Stone-free status will be assessed during postoperative follow-up. Complications will be classified according to the Clavien-Dindo classification. Additional parameters, including operative time, fluoroscopy time, length of hospital stay, infection-related laboratory findings, and the need for auxiliary procedures, will also be evaluated.

The aim of this study is to determine whether the use of an aspirating ureteral access sheath improves surgical efficiency and safety compared with a conventional sheath. The results are expected to provide evidence to guide clinical decision-making in endoscopic kidney stone surgery.

03

Conditions studied

  • Kidney Stones

Browse trials for

Keywords

  • retrograd intrarenal surgery
  • kidney stone
  • kidney
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged between 18 and 75 years
  • Patients diagnosed with kidney stones smaller than 2 cm
  • Patients scheduled for retrograde intrarenal surgery (RIRS)
  • Patients who provide written

Exclusion criteria

Exclusion Criteria:

  • Patients with active urinary tract infection
  • Patients with coagulopathy
  • Pregnant patients
  • Patients unable to tolerate the lithotomy position
  • Patients with incomplete clinical or laboratory data
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Non-aspirating ureteral access sheath

    Patients undergoing retrograde intrarenal surgery (RIRS) using a non-aspirating ureteral access sheath.

    Device: Non-aspirating ureteral access sheath

  • Experimental
    Aspirating ureteral access sheath

    Patients undergoing retrograde intrarenal surgery (RIRS) using an aspirating ureteral access sheath.

    Device: Aspirating ureteral access sheath

Interventions

  • DeviceNon-aspirating ureteral access sheath

    A conventional ureteral access sheath that allows passive outflow of irrigation fluid during RIRS.

  • DeviceAspirating ureteral access sheath

    A ureteral access sheath with an active suction system that facilitates removal of irrigation fluid and stone fragments during RIRS.

06

What researchers measure

Primary outcomes

  1. Stone-free status

    Stone-free status is defined as the absence of residual stones on low-dose non-contrast computed tomography or plain urinary system radiography at 3 weeks postoperatively.

    Time frame: At 3 weeks postoperatively

Secondary outcomes

  1. Operation time

    Operative time is defined as the duration from the start of the operation to its completion.

    Time frame: Measured during surgery, from incision to closure (intraoperative period)

  2. Length of hospital stay

    Length of hospital stay is defined as the time from postoperative hospital admission to hospital discharge, measured in days.

    Time frame: From postoperative admission to hospital discharge, assessed up to 30 days

  3. Intraoperative complications

    Intraoperative complications are defined as any adverse events occurring during the surgical procedure, including but not limited to bleeding, ureteral injury, or technical difficulties.

    Time frame: From start to completion of surgery (intraoperative period)

  4. Postoperative infectious complications

    Postoperative infectious complications are defined as infection-related adverse events occurring after surgery, including fever, urinary tract infection, and sepsis.

    Time frame: From end of surgery to 7 days postoperatively

07

Study locations

1 of 1 sites recruiting
  • Department of Urology, Hitit University Çorum Erol Olçok Training and Research Hospital, Çorum, Türkiye
    Çorum, Çorum 19040, Turkey (Türkiye)
    Recruiting
    • AHMET TAŞCI · Contactahmettasci400@gmail.com · +90 553 159 6690
    • AHMET TAŞCI · Principal investigator
    • MUSA EKİCİ · Sub investigator
08

References and documents

Publications

  • Kwok JL, Somani B, Sarica K, Yuen SKK, Zawadzki M, Castellani D, Persaud S, Chai CA, Kamal W, Tefik T, Tursunkulov AN, Soebhali B, Hajj AE, Ko R, Fong KY, Dragos L, Tanidir Y, Angerri O, Traxer O, Gauhar V. Multicenter outcome analysis of different sheath sizes for Flexible and Navigable Suction ureteral access sheath (FANS) ureteroscopy: an EAU Endourology collaboration with the global FANS study group. Urolithiasis. 2024 Nov 15;52(1):162. doi: 10.1007/s00240-024-01662-4. PubMed 39545972 ↗
  • Gauhar V, Traxer O, Castellani D, Sietz C, Chew BH, Fong KY, Hamri SB, Gokce MI, Gadzhiev N, Galosi AB, Yuen SKK, El Hajj A, Ko R, Zawadzki M, Sridharan V, Lakmichi MA, Corrales M, Malkhasyan V, Ragoori D, Soebhali B, Tan K, Chai CA, Tursunkulov AN, Tanidir Y, Persaud S, Elshazly M, Kamal W, Tefik T, Shrestha A, Tiong HC, Somani BK. Could Use of a Flexible and Navigable Suction Ureteral Access Sheath Be a Potential Game-changer in Retrograde Intrarenal Surgery? Outcomes at 30 Days from a Large, Prospective, Multicenter, Real-world Study by the European Association of Urology Urolithiasis Section. Eur Urol Focus. 2024 Dec;10(6):975-982. doi: 10.1016/j.euf.2024.05.010. Epub 2024 May 24. PubMed 38789313 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared due to privacy concerns and institutional data protection policies. All data collected in this study will be used solely for research purposes and will remain confidential.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Apr 2027, 11 months after the start.

Of 183 non-industry interventional studies with no phase under Kidney Calculi, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 54. This study's planned 11 months is below that.

Counting every sponsor, half of 199 studies reached it within 26 months; a quarter within 12 and three quarters within 51.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 17, 2026
First posted
May 6, 2026
StartActual
Apr 20, 2026
Primary completionEst.
Apr 11, 2027
CompletionEst.
May 11, 2027
Last update
Jun 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07568990
Lead sponsor
Hitit University
Responsible party
Ahmet Taşci (Research Assistant Doctor, Hitit University) — Principal investigator
First posted
May 6, 2026
Start date
Apr 20, 2026
Primary completion
Apr 11, 2027 (estimated)
Completion
May 11, 2027 (estimated)
Last update
Jun 10, 2026

Study contacts

AHMET TAŞCI
Contact
ahmettasci400@gmail.com
+905531596690

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion